LYMPHARMA Trademark

Trademark Overview


On Friday, June 12, 2020, a trademark application was filed for LYMPHARMA with the United States Patent and Trademark Office. The USPTO has given the LYMPHARMA trademark a serial number of 88962116. The federal status of this trademark filing is REGISTERED as of Tuesday, May 18, 2021. This trademark is owned by Lympharma LLc.. The LYMPHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research
lympharma

General Information


Serial Number88962116
Word MarkLYMPHARMA
Filing DateFriday, June 12, 2020
Status700 - REGISTERED
Status DateTuesday, May 18, 2021
Registration Number6358012
Registration DateTuesday, May 18, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical research

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 10, 2020
Primary Code042
First Use Anywhere DateFriday, June 12, 2020
First Use In Commerce DateSunday, March 7, 2021

Trademark Owner History


Party NameLympharma LLc.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAnn Arbor, MI 48105

Party NameLympharma LLc.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAnn Arbor, MI 48105

Trademark Events


Event DateEvent Description
Tuesday, May 18, 2021REGISTERED-SUPPLEMENTAL REGISTER
Monday, April 12, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 12, 2021ASSIGNED TO LIE
Saturday, April 10, 2021APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Thursday, March 25, 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, March 24, 2021USE AMENDMENT ACCEPTED
Saturday, March 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 12, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 12, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 13, 2021AMENDMENT TO USE PROCESSING COMPLETE
Saturday, March 13, 2021USE AMENDMENT FILED
Friday, March 12, 2021TEAS AMENDMENT OF USE RECEIVED
Wednesday, September 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 16, 2020NON-FINAL ACTION E-MAILED
Wednesday, September 16, 2020NON-FINAL ACTION WRITTEN
Wednesday, September 16, 2020ASSIGNED TO EXAMINER
Friday, July 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 16, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords


lympharma research medical